GenScript Biotech Joins PSCI, Promoting a Sustainable Pharmaceutical Future
GenScript Biotech Corporation, a recognized leader in life sciences and manufacturing services, has proudly announced its new status as a Supplier Partner with the Pharmaceutical Supply Chain Initiative (PSCI). This partnership represents a significant stride forward in the company's ongoing commitment to advancing sustainable practices and fostering a more responsible pharmaceutical industry.
PSCI focuses on the importance of ethical conduct and accountability in the pharmaceutical and healthcare sectors. Its initiatives are built on a foundation of promoting responsible supply chain practices. The organization's efforts target numerous pivotal areas, including ethics, human rights, and environmental management. Through collaborative engagement between industry leaders, PSCI aims to enhance the overall effectiveness and sustainability of supply chains, directing their members towards superior ESG (Environmental, Social, and Governance) performance.
Reflecting on this momentous partnership, Sherry Shao, the rotating CEO of GenScript Biotech, conveyed her company's enthusiasm and dedication to ethical practices. She stated, "As a responsible global enterprise in life sciences and biotechnology, we are honored to become a PSCI Supplier Partner. Our core mission is to enhance innovation across our various business segments, including life sciences services, biologics contract development, and manufacturing (CDMO), synthetic industrial products, and cell therapies. This partnership is a testament to our commitment to quality and responsible business practices."
The PSCI principles emphasize a comprehensive approach to supply chain management, prioritizing ethical standards, labor rights, and environmental sustainability. By aligning operations with PSCI's guidelines, GenScript aims to ensure that its suppliers adhere to responsible operational standards, which in turn will improve the sustainability and compliance of its supply chain.
The company's involvement with PSCI is expected to elevate its ESG benchmarks and further advocate for ethical labor practices and health and safety protocols within its operations and supply chain. GenScript looks to cultivate enduring collaborations with clients, navigating through diverse global regulations while fostering a network of responsible suppliers.
Founded in 2002 in New Jersey, GenScript Biotech has established its reputation as a pioneering force in biotechnology, striving to make healthcare solutions more accessible while enhancing the quality of life for people and nature alike. Guided by its mission of improving health through biotechnology, the organization employs over 5,000 staff members and serves more than 200,000 customers across 100 countries.
The company’s decision to align with PSCI highlights its strategic focus on combating systemic challenges within the pharmaceutical industry through innovative solutions. GenScript's proactive role as a Supplier Partner in PSCI accentuates its mission to contribute positively to a brighter future for the global healthcare landscape.
As this collaboration unfolds, GenScript looks forward to showcasing the positive impacts of its partnership with PSCI, encouraging other organizations to commit to responsible business practices, and collectively working towards a more sustainable and equitable pharmaceutical industry.
PSCI focuses on the importance of ethical conduct and accountability in the pharmaceutical and healthcare sectors. Its initiatives are built on a foundation of promoting responsible supply chain practices. The organization's efforts target numerous pivotal areas, including ethics, human rights, and environmental management. Through collaborative engagement between industry leaders, PSCI aims to enhance the overall effectiveness and sustainability of supply chains, directing their members towards superior ESG (Environmental, Social, and Governance) performance.
Reflecting on this momentous partnership, Sherry Shao, the rotating CEO of GenScript Biotech, conveyed her company's enthusiasm and dedication to ethical practices. She stated, "As a responsible global enterprise in life sciences and biotechnology, we are honored to become a PSCI Supplier Partner. Our core mission is to enhance innovation across our various business segments, including life sciences services, biologics contract development, and manufacturing (CDMO), synthetic industrial products, and cell therapies. This partnership is a testament to our commitment to quality and responsible business practices."
The PSCI principles emphasize a comprehensive approach to supply chain management, prioritizing ethical standards, labor rights, and environmental sustainability. By aligning operations with PSCI's guidelines, GenScript aims to ensure that its suppliers adhere to responsible operational standards, which in turn will improve the sustainability and compliance of its supply chain.
The company's involvement with PSCI is expected to elevate its ESG benchmarks and further advocate for ethical labor practices and health and safety protocols within its operations and supply chain. GenScript looks to cultivate enduring collaborations with clients, navigating through diverse global regulations while fostering a network of responsible suppliers.
Founded in 2002 in New Jersey, GenScript Biotech has established its reputation as a pioneering force in biotechnology, striving to make healthcare solutions more accessible while enhancing the quality of life for people and nature alike. Guided by its mission of improving health through biotechnology, the organization employs over 5,000 staff members and serves more than 200,000 customers across 100 countries.
The company’s decision to align with PSCI highlights its strategic focus on combating systemic challenges within the pharmaceutical industry through innovative solutions. GenScript's proactive role as a Supplier Partner in PSCI accentuates its mission to contribute positively to a brighter future for the global healthcare landscape.
As this collaboration unfolds, GenScript looks forward to showcasing the positive impacts of its partnership with PSCI, encouraging other organizations to commit to responsible business practices, and collectively working towards a more sustainable and equitable pharmaceutical industry.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.